Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03101826
Other study ID # 1609337519
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date November 1, 2017
Est. completion date March 8, 2023

Study information

Verified date March 2023
Source Indiana University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The Polyvagal Theory focuses on how function and structure changed in the vertebrate autonomic nervous system during evolution. The theory is named for the vagus, a major cranial nerve that regulates bodily state. As a function of evolution, humans and other mammals have a "new" vagal pathway that links the regulation of bodily state to the control of the muscles of the face and head including the middle ear muscles. These pathways regulating body state, facial gesture, listening (i.e., middle ear muscles), and vocal communication collectively function as a Social Engagement System (SES). Because the Social Engagement System is an integrated system, interventions influencing one component of this system (e.g., middle ear muscles) may impact on the other components. Individuals with Prader-Willi Syndrome (PWS) exhibit many behaviors that are consistent with a compromised Social Engagement System. Atypical function of the Social Engagement System results in problems associated with state regulation (e.g., impulsivity, tantrums, and difficulty with change in routine), ingestion (e.g., difficulties in sucking at birth, hyperphagia), coordination of suck/swallow/breathe, intonation of vocalizations, auditory processing and hypersensitivity, and socialization. We propose to confirm that several features of the behavioral phenotype of PWS may be explained within the context of a dysfunctional SES (Specific Aim I), which may be partially rehabilitated via an intervention designed as a 'neural exercise' of the SES (Specific Aim II). Specific Aims: Aim I: To demonstrate that children with PWS have atypical regulation of the SES. We hypothesize these effects will be manifested by dampened vagal regulation of the heart (low parasympathetic tone); poor middle ear muscle regulation resulting in auditory hypersensitivities and poor auditory processing; lack of voice intonation (prosody), and difficulties in accurately detecting the emotions of others. Aim II: To demonstrate the effectiveness of the Listening Project Protocol (LPP) in decreasing the atypical features of the SES in adolescents with PWS. We hypothesize that individuals who complete the LPP will have improved vagal regulation of the heart, improved middle ear muscle regulation, increased voice intonation and improved ability to accurately detect the emotions of others.


Recruitment information / eligibility

Status Terminated
Enrollment 5
Est. completion date March 8, 2023
Est. primary completion date March 8, 2023
Accepts healthy volunteers No
Gender All
Age group 13 Years to 25 Years
Eligibility Inclusion Criteria: 1. Participants must be current residents at Latham Centers (LC) School in Brewster MA 2. Participants must meet criteria for Prader-Willi Syndrome 3. Participants must be between ages 13 - 25 years 4. Participants must have normal hearing 5. Participants must have normal vision (or corrected vision) Exclusion Criteria: 1. Individuals with current (or a history of) heart disease 2. Individuals who are hearing-impaired 3. Individuals who are being treated for seizure disorder 4. Individuals who do not read/speak English 5. Individuals who are sight-impaired without correction

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Listening Project Protocol
The filtered music intervention will consist of listening to computer-altered acoustic stimulation, designed to modulate the frequency band of vocal music passed to the participant. The frequency characteristics of the acoustic stimulation are selected to emphasize the relative importance of specific frequencies in conveying the information embedded in human speech Modulation of the acoustic energy within the frequencies of human voice, similar to an exaggerated vocal prosody, are hypothesized to recruit and modulate the neural regulation of the middle ear muscles and to functionally reduce sound hypersensitivities and improve auditory processing.

Locations

Country Name City State
United States Latham Centers School Brewster Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Indiana University Latham Centers

Country where clinical trial is conducted

United States, 

References & Publications (6)

Bal E, Harden E, Lamb D, Van Hecke AV, Denver JW, Porges SW. Emotion recognition in children with autism spectrum disorders: relations to eye gaze and autonomic state. J Autism Dev Disord. 2010 Mar;40(3):358-70. doi: 10.1007/s10803-009-0884-3. — View Citation

Borg E, Counter SA. The middle-ear muscles. Sci Am. 1989 Aug;261(2):74-80. doi: 10.1038/scientificamerican0889-74. No abstract available. — View Citation

Lewis GF, Furman SA, McCool MF, Porges SW. Statistical strategies to quantify respiratory sinus arrhythmia: are commonly used metrics equivalent? Biol Psychol. 2012 Feb;89(2):349-64. doi: 10.1016/j.biopsycho.2011.11.009. Epub 2011 Dec 3. — View Citation

Porges SW, Bazhenova OV, Bal E, Carlson N, Sorokin Y, Heilman KJ, Cook EH, Lewis GF. Reducing auditory hypersensitivities in autistic spectrum disorder: preliminary findings evaluating the listening project protocol. Front Pediatr. 2014 Aug 1;2:80. doi: 10.3389/fped.2014.00080. eCollection 2014. — View Citation

Porges SW, Macellaio M, Stanfill SD, McCue K, Lewis GF, Harden ER, Handelman M, Denver J, Bazhenova OV, Heilman KJ. Respiratory sinus arrhythmia and auditory processing in autism: modifiable deficits of an integrated social engagement system? Int J Psychophysiol. 2013 Jun;88(3):261-70. doi: 10.1016/j.ijpsycho.2012.11.009. Epub 2012 Nov 29. — View Citation

Porges SW. The polyvagal theory: phylogenetic substrates of a social nervous system. Int J Psychophysiol. 2001 Oct;42(2):123-46. doi: 10.1016/s0167-8760(01)00162-3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Stability of Autonomic regulation Respiratory sinus arrhythmia (RSA) Change from 6 months pre-intervention RSA to 1 week pre-intervention
Other Immediate effects of intervention on Autonomic regulation Respiratory sinus arrhythmia (RSA) Change from 1 week pre-intervention RSA to 1 week post-intervention
Other Short-term effects of intervention on Autonomic regulation Respiratory sinus arrhythmia (RSA) Change from 1 week post-intervention RSA to 1 month post-intervention
Other Stability of Heart period heart period Change from 6 months pre-intervention heart period to 1 week pre-intervention
Other Immediate effects of intervention on Heart period heart period Change from 1 week pre-intervention heart period to 1 week post-intervention
Other Short-term effects of intervention on Heart period heart period Change from 1 week post-intervention heart period to 1 month post-intervention
Other Stability of Auditory processing Filtered Words subtest of SCAN Change from 6 months pre-intervention Filtered Words to 1 week pre-intervention
Other Immediate effects of intervention on Auditory processing Filtered Words subtest of SCAN Change from 1 week pre-intervention Filtered Words to 1 week post-intervention
Other Short-term effects of intervention on Auditory processing Filtered Words subtest of SCAN Change from 1 week post-intervention Filtered Words to 1 month post-intervention
Other Stability of Auditory processing Competing Words subtest of SCAN Change from 6 months pre-intervention Competing Words to 1 week pre-intervention
Other Immediate effects of intervention on Auditory processing Competing Words subtest of SCAN Change from 1 week pre-intervention Competing Words to 1 week post-intervention
Other Short-term effects of intervention on Auditory processing Competing Words subtest of SCAN Change from 1 week post-intervention Competing Words to 1 month post-intervention
Other Stability of Sensory Sensitivities BBC Sensory Scales (questionnaire) Change from 6 months pre-intervention BBC Sensory Scales to 1 week pre-intervention
Other Stability of Latency to Affect recognition Dynamic Affect Recognition Evaluation (DARE) - latency Change from 6 months pre-intervention DARE latency to 1 week pre-intervention
Other Immediate effects of intervention on Latency to Affect recognition Dynamic Affect Recognition Evaluation (DARE) - latency Change from 1 week pre-intervention DARE latency to 1 week post-intervention
Other Short-term effects of intervention on Latency to Affect recognition Dynamic Affect Recognition Evaluation (DARE) - latency Change from 1 week post-intervention DARE latency to 1 month post-intervention
Other Stability of Accuracy of Affect recognition Dynamic Affect Recognition Evaluation (DARE) - accuracy Change from 6 months pre-intervention DARE accuracy to 1 week pre-intervention
Other Immediate effects of intervention on Accuracy of Affect recognition Dynamic Affect Recognition Evaluation (DARE) - accuracy Change from 1 week pre-intervention DARE accuracy to 1 week post-intervention
Other Short-term effects of intervention on Accuracy of Affect recognition Dynamic Affect Recognition Evaluation (DARE) - accuracy Change from 1 week post-intervention DARE accuracy to 1 month post-intervention
Other Stability of Prosody Analyses of vocal recordings Change from 6 months pre-intervention prosody to 1 week pre-intervention
Other Immediate effects of intervention on Prosody Analyses of vocal recordings Change from 1 week pre-intervention prosody to 1 week post-intervention
Other Short-term effects of intervention on Prosody Analyses of vocal recordings Change from 1 week post-intervention prosody to 1 month post-intervention
Other Stability of Disruptive behavior Developmental Behavior Checklist (DBC) (questionnaire) Change from 6 months pre-intervention DBC to 1 week pre-intervention
Other Immediate effects of intervention on Disruptive behavior Developmental Behavior Checklist (DBC) (questionnaire) Change from 1 week pre-intervention DBC to 1 week post-intervention
Other Short-term effects of intervention on Disruptive behavior Developmental Behavior Checklist (DBC) (questionnaire) Change from 1 week post-intervention DBC to 1 month post-intervention
Other Stability of Oxytocin oxytocin levels derived from salivary sample Change from 6 months pre-intervention oxytocin to 1 week pre-intervention
Other Stability of Vasopressin vasopressin levels derived from salivary sample Change from 6 months pre-intervention vasopressin to 1 week pre-intervention
Primary Effect of Intervention on Autonomic regulation Respiratory sinus arrhythmia (RSA) Change from 1 week pre-intervention RSA to 1 month post-intervention
Secondary Effect of Intervention on Heart period heart period Change from 1 week pre-intervention heart period to 1 month post-intervention
Secondary Effect of Intervention on Auditory processing Filtered Words subtest of SCAN Change from 1 week pre-intervention Filtered Words to 1 month post-intervention
Secondary Effect of Intervention on Auditory processing Competing Words subtest of SCAN Change from 1 week pre-intervention Competing Words to 1 month post-intervention
Secondary Effect of Intervention on Sensory Sensitivities BBC Sensory Scales (questionnaire) Change from 1 week pre-intervention BBC Sensory Scales to 1 month post-intervention
Secondary Effect of Intervention on Latency to Affect recognition Dynamic Affect Recognition Evaluation (DARE) - latency Change from 1 week pre-intervention DARE (latency) to 1 month post-intervention
Secondary Effect of Intervention on Accuracy of Affect recognition Dynamic Affect Recognition Evaluation (DARE) - accuracy Change from 1 week pre-intervention DARE (accuracy) to 1 month post-intervention
Secondary Effect of Intervention on Prosody Analyses of vocal recordings Change from 1 week pre-intervention Prosody to 1 month post-intervention
Secondary Effect of Intervention on Disruptive Behavior Developmental Behavior Checklist (DBC) (questionnaire) Change from 1 week pre-intervention DBC to 1 month post-intervention
Secondary Effect of Intervention on Social behavior Listening Project Parent (LPP) Questionnaire Change from 1 week post-intervention LPP to 1 month post-intervention
Secondary Effect of Intervention on Oxytocin oxytocin levels derived from salivary sample Change from 1 week pre-intervention oxytocin to 1 month post-intervention
Secondary Effect of Intervention on Vasopressin vasopressin levels derived from salivary sample Change from 1 week pre-intervention vasopressin to 1 month post-intervention
See also
  Status Clinical Trial Phase
Recruiting NCT05032326 - Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial Phase 3
Completed NCT04526379 - Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation N/A
Terminated NCT03458416 - A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome Phase 2
Completed NCT03718416 - Natural History Study of Serious Medical Events in PWS
Completed NCT05322096 - Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome Phase 2
Completed NCT02205450 - Growth Hormone in Children Under 2 Years With Prader-Willi in Hospital of Sabadell
Terminated NCT02179151 - Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome Phase 3
Completed NCT00375089 - Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity N/A
Completed NCT00004351 - Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes N/A
Recruiting NCT05938543 - Cerebellar TMS and Satiety in Prader-Willi Syndrome N/A
Suspended NCT05879614 - An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001) Phase 2
Recruiting NCT03031626 - Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome Phase 4
Withdrawn NCT04086810 - An Open-Label Study of DCCR Tablet in Patients With PWS Phase 3
Completed NCT02629991 - Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome Phase 2
Recruiting NCT02297022 - Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome Phase 1
Not yet recruiting NCT02263781 - PREPL in Health and Disease N/A
Completed NCT00551343 - Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome N/A
Recruiting NCT06448871 - Ultrasound to Assess Sarcopenia in Prader Willi Syndrome
Enrolling by invitation NCT03655223 - Early Check: Expanded Screening in Newborns
Recruiting NCT05939453 - Impact of Bright Light Therapy on Prader-Willi Syndrome N/A